using clinical pharmacology & pharmacometrics to accelerate car-t development
Published 1 year ago • 1.2K plays • Length 55:32Download video MP4
Download video MP3
Similar videos
-
30:56
a drug development software and services overview with a focus on rsnlme and simcyp
-
44:12
quantitative systems pharmacology for drug discovery and development
-
49:35
quantitative and systems pharmacology approaches for the development of oncology drugs
-
57:36
project optimus & pediatric drug development
-
43:49
how can model informed drug development impact your program?
-
11:17
car-t cells: engineered cancer killers
-
3:21
india's homegrown, low-cost car-t cell therapy | the race to cure cancer | latest news | wion
-
9:51
dual car-t therapy for hiv- results of phase ii study.
-
3:14
car t-cell therapy explained (manufacturing process & how it works)
-
7:30
car-t cell therapy explained
-
2:01
how does car t-cell therapy work?
-
4:51
car-t cell therapy: side-effects and neurotoxicity
-
44:17
the promises and pitfalls of gene therapy for rare diseases
-
5:17
car t-cell therapies | high impact topic (hit)
-
48:15
a pbpk platform model to guide intravenous and subcutaneous dosing for bispecific t cell engagers
-
1:05:52
application of physiologically-based pharmacokinetics (pbpk) to personalized dosing
-
3:58
manufacturing car t cells to accelerate cancer immunotherapy research
-
2:22
combining car-ts & bispecific antibodies
-
1:21
car t cell therapy - how does it work?
-
2:08
car t-cell therapy | mesothelioma | respirework
-
3:52
is car t-cell therapy being used to treat newly diagnosed multiple myeloma?
-
18:33
car t-cell therapy: reprogramming the immune system to treat cancer | rob weinkove | tedxtauranga